Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Evogene Ltd. - Ordinary Shares (NQ: EVGN ) 1.900 -0.040 (-2.06%) Streaming Delayed Price Updated: 4:00 PM EST, Jan 3, 2025 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Evogene Ltd. - Ordinary Shares < Previous 1 2 3 Next > Earnings Scheduled For November 21, 2024 November 21, 2024 Via Benzinga A Glimpse of Evogene's Earnings Potential November 20, 2024 Via Benzinga EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024 August 22, 2024 EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024 May 23, 2024 EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023 March 07, 2024 EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace Evogene Earnings Preview March 06, 2024 Via Benzinga Recap: Evogene Q3 Earnings November 15, 2023 Via Benzinga A Preview Of Evogene's Earnings November 14, 2023 Via Benzinga Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know August 18, 2023 Via Benzinga Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party' March 07, 2024 Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported... Via Benzinga Topics Cannabis Exposures Cannabis Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges November 16, 2023 Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech. Via Benzinga Topics Cannabis Exposures Cannabis Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023 October 02, 2023 Via Benzinga Earnings Outlook For Evogene August 16, 2023 Via Benzinga Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds July 03, 2023 Evogene Ltd. (NASDAQ: EVGN) said its unit Casterra Ag Ltd. Via Benzinga TalkMarkets Announces Company Spotlight Featuring Evogene June 22, 2023 TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology. Via Talk Markets Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga Evogene: Q1 Earnings Insights May 18, 2023 Via Benzinga Why Evogene Shares Are Moving September 21, 2023 Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the... Via Benzinga Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets August 17, 2023 Cannabis company Evogene Ltd. Via Benzinga Topics Cannabis Exposures Cannabis Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 17, 2023 Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... Via Benzinga Evogene's Earnings Outlook May 17, 2023 Via Benzinga Why Evogene Stock Is Tanking Today July 17, 2023 Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) shares were trading 20% lower at $1.12 per share at the time of writing Monday morning. Via Benzinga Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 14, 2023 Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday. Via Benzinga TalkMarkets Announces Company Spotlight Featuring Evogene June 22, 2023 TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology. Via News Direct Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value June 22, 2023 From a sum-of-parts perspective, Evogene is likely worth many multiples of its market valuation today, even without ascribing any value to Evogene’s technology. Via Talk Markets Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 21, 2023 Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak... Via Benzinga Why Evogene (EVGN) Stock Is Trading Higher June 21, 2023 Evogene Ltd (NASDAQ: EVGN) shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to... Via Benzinga Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS May 24, 2023 Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S. Via Benzinga Evogene Q1 Revenue Grows 170% YoY, Here Are The Details May 18, 2023 Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in... Via Benzinga Earnings Scheduled For May 18, 2023 May 18, 2023 Companies Reporting Before The Bell • Lightspeed Commerce (NYSE:LSPD) is projected to report quarterly loss at $0.04 per share on revenue of $248.01 million. Via Benzinga < Previous 1 2 3 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
